Trials / Completed
CompletedNCT00245557
Magnetic Resonance Imaging Study of Geriatric Depression
Nuclear Magnetic Resonance Imaging Study of Treatment With Sertraline in Geriatric Depression
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Mclean Hospital · Academic / Other
- Sex
- All
- Age
- 55 Years – 89 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to use Magnetic Resonance Images to further our understanding of predictors and markers of treatment response and non-response in geriatric depression. We hypothesized that concentrations of high energy metabolites would be lower in depressed elderly compared to non-depressed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sertraline | Oral Sertraline Dosage started at 25 mg a day, with increases up to maximum dosage strength of 200 mg a day. Duration of treatment was 12 weeks. |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2005-10-28
- Last updated
- 2017-03-30
- Results posted
- 2010-02-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00245557. Inclusion in this directory is not an endorsement.